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ABSTRACT In this study, following our earlier work on calcium pyrophosphate dihydrate (CPPD) crystal-induced mem-
branolysis, we demonstrate, using the CHARMM method of molecular dynamics simulation, the protective role of phosph-
ocitrate (PC) against solvated dimyristoyl phosphatidylcholine phospholipid bilayer disintegration on contact with the CPPD
crystal. Our molecular dynamics simulations studies show that coverage of the CPPD crystal with a layer of phosphocitrate
molecules results in the conservation of phospholipid bilayer integrity. We show that the rupture of the lipid bilayer in presence
of CPPD and the protective effect of PC are primarily due to electrostatic interactions. The protective role of PC, which may also
play an important and potentially therapeutic function against crystal-induced membranolysis is also discussed.
INTRODUCTION
Inﬂammation in the inﬂammatory diseases such as arthritis
is proposed to be due to the rupture of the lysosome phosph-
olipid membrane and the release of lysosomal enzymes into
the cytoplasm. The rupture of the membrane or mem-
branolysis is usually accompanied by the crystal deposition
near the membrane (1–4). Calcium pyrophosphate dihydrate
(CPPD) crystal is one of the most common forms of
pathologic articular mineral, and its deposition leads to
pseudogout, an inﬂammatory disease. The crystal deposition
increases in prevalence with aging (50% at the age of 90
years) and occurs frequently in degenerative joints. Although
deposition occurs frequently in noninﬂammatory osteoar-
thritic (OA) joints, it can be phlogistic, causing acute attacks
of pseudogout.
Pathologic crystals (e.g., CPPD) that induce membra-
nolysis can be differentiated from nonpathologic crystals by
their surface charge and topography. Pathologic crystals, also
known as membranolytic crystals such as monosodium
urate, CPPD, and the a-quartz form of silicon dioxide, are
irregular and possess a high density of negatively charged
groups as compared to nonmembranolytic smooth surface
crystals, e.g., diamond dust and the anatase form of silicon
dioxide. The less negatively surface-charged brushite and hy-
droxyapatite crystals are not often associated with acute
inﬂammation (5).
Until recently, only indirect evidence of the crystal-
membrane interactions have been presented. For example, it
has been demonstrated that the adhesion of calcium oxalate
monohydrate crystals involves anionic sites on the surface of
renal epithelial cells (6,7). In another related study (8) involv-
ing different classes of anionic crystals, namely hydroxyap-
atite, it has been also speculated that the interaction between
renal epithelial cells and hydroxyapatite crystal surfaces
involves negatively charged molecules protruding from the
apical surface of the plasma membrane. However, very re-
cently, employing computational techniques, we have pre-
sented direct evidence that the crystal-membrane interaction
leads to a rupture of the lipid bilayer (1). We have proposed
that the interactions between the surface of the CPPD crystal
and the extracellular layer of the hydrated dimyristoyl phos-
phatidylcholine (DMPC) phospholipid bilayer may lead to
decoupling of the external layer from the intracellular side of
the membrane. In turn, a local thinning of the layer on the
intracellular side of the membrane occurs, which favors
water penetration, leading to membranolysis.
Understanding these interactions at the molecular level is
extremely helpful, not only to elucidate the molecular nature
of cell-crystal interaction, but also to aid in design of ther-
apeutic agents that could diminish such an interaction. There
is already some experimental evidence that phosphocitrate, a
polyanion, protects from crystal-induced polymorphonuclear
leukocyte membranolysis (9). The CPPD crystal surface,
although neutral, contains loci of both positive and negative
charges, and is able to attract complementarily charged mol-
ecular species, like the highly negatively charged (4)
phosphocitrate anion. Studies of interactions between ionic
crystals and phospholipid bilayers show that these inter-
actions can be modiﬁed by polyanions like phosphocitrate,
citrate, polyasparate, and polyglutamate. Our earlier molec-
ular modeling studies show that phosphocitrate could be
used as a powerful inhibitor of the (010) crystal surfaces of
CPPD crystal (10).
In this work we have undertaken computational model-
ing studies to determine the effect of phosphocitrate on the
CPPD-induced membranolysis of the DMPC phospholipid
bilayers. We show that phosphocitrate greatly inhibits the
CPPD-induced membranolysis.
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METHODS
The generation of the solvated DMPC lipid bilayer with a CPPD crystal and
the lipid/water interface is described in detail in our earlier study (1). The
same lipid bilayer system was employed in these simulations. The solvated
lipid bilayer system used in the simulations was 48 3 32 3 88 A˚. In this
study we employed a slightly different slab of the CPPD crystal. To maintain
the neutrality of the CPPD-PC system, we prepared the CPPD crystal slab,
which had a total charge of132. Subsequently, using Monte Carlo docking,
eight phosphocitrate ions (4 charge each) were docked on the crystal in
a sequential fashion. Initially, a phosphocitrate ion was placed .10 A˚ away
from the CPPD crystal. A Monte Carlo simulation was performed at this
point (5000 steps) to identify the most favorable position and orientation of
the phosphocitrate ion by determining the most favorable interaction energy
of the phosphocitrate ion on the CPPD crystal. After the docking of the ﬁrst
phosphocitrate ion, a second phosphocitrate ion was placed on the resulting
system in a similar fashion. We found that both the phosphocitrate ions were
the same distance from the crystal and oriented identically in space. Hence,
for docking of subsequent phosphocitrate ions, the distance of the ion and its
orientation were held ﬁxed. With the aid of such Monte Carlo docking
simulations, we covered the CPPD surface with eight phosphocitrate ions
(total charge ¼ 32). The resulting system was neutral (CPPD crystal ¼
132 and phosphocitrate ions ¼ 32).
The complex of CPPD crystal and eight phosphocitrate ions was placed
at the lipid bilayer/water interface. The initial position of the crystal was
determined from our previous study. However, because the height of phos-
phocitrate ion is 5 A˚, we moved the CPPD-phosphocitrate ion complex 5 A˚
away from the lipid bilayer from the initial position. During the simulation,
the position of CPPD-PC complex was held ﬁxed. In this study the
simulation time for the bilayer and the bilayer-CPPD-PC was 1.2 ns. Other
simulation details are described in detail in our previous study (1).
RESULTS
Shown in Fig. 1 are the side and top views of the complex of
CPPD crystal and eight phosphocitrate ions. As is evident
from the ﬁgure, the PC ions occupy similar lattice positions
on the crystal. This particular orientation of PC ions on the
CPPD crystal allows the maximum interaction between the
electronegative oxygen atoms of the PC ions and the positive
calcium ions of the CPPD crystal. This complex of CPPD-
PC was employed in our simulations.
In our previous study (1), the molecular dynamics sim-
ulations of solvated lipid bilayer in the presence of the CPPD
crystal have shown that the phospholipid bilayer disinte-
grates during the 600-ps simulation time (Fig. 6 in Wierzbicki
et al. (1)). Furthermore, we observed that the crystal sta-
bilizes the adjacent leaﬂet, while destabilizing the lipid
leaﬂet on the opposite side. We also observed that the water
penetrates the bilayer from the side, which is opposite to the
crystal. In this study we placed CPPD at the same distance
from the bilayer as observed in the CPPD-PC system. We
observed similar leakage of the bilayer as the earlier
simulations (1).
Fig. 2 shows the results from this study in which the
CPPD-PC complex was placed at the lipid/water interface of
the solvated lipid bilayer system. Shown in this ﬁgure are the
snapshots (200 ps apart) from our molecular dynamics
simulations. As observed from the ﬁgure, the lipid bilayer
integrity is maintained. We observe that the waters do not
penetrate the lipid bilayer. This clearly indicates that PC
has a protective effect on the CPPD-induced lipid bilayer
leakage.
Fig. 3 depicts number proﬁle plots in which we have
calculated the average number of the water oxygen and lipid
nitrogen atoms in the solvated lipid bilayer-CPPD-PC over
0–200, 200–400, 400–600, and 1000–1200 ps. These plots
show the number of water O atoms (Fig. 3 A) and the
headgroup N atoms of the lipid bilayer (Fig. 3 B) across the
water/lipid interface in the solvated lipid bilayer-CPPD-PC
system. These ﬁgures clearly show that the water molecules
are outside the bilayer and do not penetrate into the bilayer
throughout the simulation. The headgroup N atoms are
distributed evenly, and the majority of them lie in the same
plane (Fig. 3 B). These properties are also clearly evident
from Fig. 2. Fig. 3, A and B, show that in the presence of the
FIGURE 1 (A) Side view of the CPPD-PC complex. The CPPD crystal
(bottom) complexed with eight phosphocitrate ions (top) is shown. The
crystal is shown in ball-and-stick conﬁguration, whereas the PC is shown in
stick conﬁguration. The hydrogens are not shown for clarity. The color
coding is as follows: pyrophosphate, gray; water, red; calcium, yellow; and
phosphocitrate, blue. (B) Top view of the CPPD-PC complex. The top view
of the CPPD crystal complexed with eight phosphocitrate ions is shown. The
oxygen atoms of the water molecules in the crystal and the calcium ions in
the crystal are shown in ball conﬁguration. The pyrophosphate part of the
CPPD crystal and PC ions are shown in stick conﬁguration. The hydrogens
are not shown for clarity. The color coding is as follows: pyrophosphate,
gray; water, red; calcium, yellow; and phosphocitrate, blue.
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CPPD crystal covered with a layer of PC, the phospholipid
bilayer remains remarkably stable even when the simulation
time is doubled from 600 to 1200 ps. Because doubling the
simulation time does not produce any further changes in our
solvated lipid bilayer-CPPD-PC system, we will use the data
obtained for the ﬁrst 600 ps of our simulation time to more
directly compare the results of this study with our earlier
600-ps study of the solvated lipid bilayer-CPPD system
without PC (1).
In our previous study, in the simulation involving only
the lipid bilayer (without the CPPD crystal), the diffusion
coefﬁcient of the nitrogen atoms of the lipid headgroup was
relatively similar. For the bottom layer, we calculated a value
of 0.55 3 102 6 0.9 3 104 A˚2/ps and for the top layer,
0.69 3 102 6 0.16 3 103 A˚2/ps. However, the values
were quite different for the simulations in which we placed
the crystal at the bottom lipid leaﬂet. In those simulations,
for the bottom layer (interacting with crystal) we obtained
a value of 0.163 1026 0.13 104 A˚2/ps, whereas for the
top layer we obtained a value of 2.4 3 102 6 0.21 3 103
A˚2/ps. Thus, we observed that the lipid headgroups near the
crystal had a reduced mobility, and the ones on the far end
had an increased mobility compared to a solvated lipid
bilayer in the absence of the crystal. Similarly, we measured
the headgroup mobility in the current simulations. In this
study, we determined that the diffusion coefﬁcient of the
nitrogen atoms of the lipid headgroups near the CPPD-PC
complex was 0.423 1026 0.553 104 A˚2/ps, whereas for
those on the opposite side it was 0.313 1016 0.943 103
A˚2/ps. Thus, we observe in this simulation that, in the
presence of PC, the mobility of the lower (external) layer is
almost the same as for the solvated bilayer. The upper
(internal) layer on the opposite side has a higher mobility,
similar to that observed in the simulation of lipid bilayer in
the presence of the CPPD crystal (Table 1). However, it must
be noted here that the ratio of mobilities between the upper
and lower layers decreased from 15 to 7.4 for the bilayer-
CPPD and bilayer-PC-CPPD, respectively. Despite the ele-
vated mobility of the opposite leaﬂet, the bilayer-PC-CPPD
system does not break, which indicates that the underlying
mechanism is not mobility driven.
To verify that the lipid bilayer breakdown for bilayer-
CPPD system is not caused by difference in the lipid mo-
bility in the upper and lower layers, as we proposed earlier in
Wierzbicki et al. (1), we did a simulation of solvated lipid
bilayer in which we kept the headgroups of the bottom leaﬂet
ﬁxed (diffusion coefﬁcient ¼ 0 A˚2/ps). We observed that the
headgroups on the opposite side showed no signiﬁcant in-
crease in the mobility and the lipid bilayer was intact during
the simulation time. These results suggest that the break-
down of the integrity of the lipid bilayer in the bilayer-PC
system is not due to change in mobility of the lipid
headgroups.
In our simulations of the bilayer-CPPD system, we ob-
served that the penetrating water molecules were all oriented
in the same way, with oxygen atoms pointing at the crystal
and hydrogen atoms pointing away from the crystal. This led
us to propose an alternative mechanism of the breakdown of
the lipid bilayer, which could be driven by the electrostatic
interactions instead. Under this hypothesis, the electrostatic
ﬁeld induced by the crystal should alter the lipid headgroup
dipole orientation and hence its orientation with respect to
FIGURE 2 Snapshots from the simulation of a solvated lipid bilayer with a CPPD crystal at one of the lipid/water interfaces are shown. The magenta spheres
indicate the oxygen atoms of the water molecules. The lipid molecules are shown as chains. The crystal is depicted at the lower lipid/water interface using ball-
and-stick scheme, and the phosphocitrate is shown in stick conﬁguration. The color scheme for the lipid headgroups, CPPD, and PC is: oxygen, red;
phosphorus, yellow; carbon, cyan; nitrogen, blue; and calcium, gold. The snapshots shown here are 200 ps apart, time advancing from left to right.
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the bilayer normal. To test this hypothesis, we calculated
the angle between the lipid bilayer normal and the vector
deﬁned by the P and N atoms of the lipid headgroup. This
angle was calculated for individual lipid headgroups for
bottom and top leaﬂets from coordinates saved every 1 ps.
The data from the individual lipid molecules were combined
together for the top and the bottom leaﬂet and subsequently
histogrammed (Fig. 4). These results show that the distri-
bution of the angles for the solvated bilayer and the bilayer-
PC-CPPD system are symmetrically distributed and highly
similar for both the leaﬂets. On the other hand, the distri-
bution for the bilayer-CPPD system is different. The distri-
bution of the angles for the top leaﬂet is shifted to the left,
reﬂecting the electrostatic force on the headgroup due to the
crystal. Interestingly, the angle distribution is affected to a
much lesser extent for the bottom leaﬂet. These results and
observations lead us to conclude that the waters and lipid
headgroups are electrostatically affected by the crystal and
that waters get pulled through the bilayer leading to break-
down of the integrity of the bilayer, which leads to the
increased mobility of the lipid headgroups.
DISCUSSION
In the ﬁrst study of its kind (1), we recently showed clearly
that the CPPD crystal causes the loss of lipid bilayer in-
tegrity. This model now provides us with a great tool in elu-
cidating the mechanism of the crystal-induced cell damage.
This is a great step forward in understanding and treating
inﬂammatory diseases such as arthritis.
We have previously shown (10) that phosphocitrate binds
to the speciﬁc faces of CPPD and proposed that this induces
morphological changes that may lead to diminished crystal
growth or its total cessation. The orientation of PC binding to
CPPD crystal obtained in our previous study is slightly dif-
ferent from the one obtained in the current study. However,
the main features are identical: the phosphate group of PC
places itself in the position at the surface that would be oc-
cupied by pyrophosphate ion, assuming crystal lattice would
have continued upward. Furthermore, the electronegative
carboxylate groups of PC are placed near the positive
calcium ions of CPPD.
In vitro experiments have shown that PC inhibits CPPD
crystal formation in isolated articular cartilage vesicles.
Cheung et al. (11) showed that PC (10–100 mM) blocked
both ATP-dependent and -independent mineralization in
articular cartilage vesicles. PC has also been shown to be
a potent in vitro inhibitor of basic calcium phosphate (BCP)
(12) (another pathologic articular mineral) and calcium
oxalate monohydrate (13,14) crystal formation.
FIGURE 3 Density proﬁles of water and lipid molecules. Fig. 3, A and
B, show the number of the oxygen atoms of the water molecules and the
number of lipid headgroup nitrogen atoms, respectively, along the water/
lipid interface when the CPPD/PC complex is present at the bottom lipid
layer. The data are presented as time-averaged series. The averages from 0 to
200 ps (solid line), 200–400 ps (solid line with circles), 400–600 ps (dashed
line), and 1000–1200 ps (solid line with open squares) are presented. The x
axis depicts the position along the lipid/water interface, 0 being the center
of the bilayer, whereas the number of atoms is plotted on the y axis. The
negative coordinates are below the center of the bilayer, and the positive
coordinates are above the center (see Fig. 2). The dashed lines within the
graph indicate the position of the bilayer-water interface.













Top layer 0.69 3 102 6 0.16 3 103 2.4 3 102 6 0.21 3 103 3.1 3 102 6 0.94 3 103 0.98 3 102 6 0.54 3 103
Bottom layer 0.55 3 102 6 0.09 3 103 0.16 3 102 6 0.01 3 103 0.42 3 102 6 0.05 3 103 0
The average diffusion coefﬁcient values are provided for the N atoms of the lipid headgroups for each layer of the lipid bilayer. The CPPD and CPPD/PC
complexes were placed adjacent to the bottom layer.
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It has been demonstrated that PC inhibits CPPD and BCP
crystal-induced mitogenesis and metalloproteinase synthesis
and secretion by ﬁbroblasts and chondrocytes (15,16). There
are other in vitro studies investigating the preventive effect
of PC on CPPD- and BCP-induced biological damage. More-
over, as mentioned earlier, it has also been shown that PC
binds these crystals. However, this is the ﬁrst computational
study that clearly shows the protective effect of PC on
CPPD-induced lipid bilayer breakdown.
The results reported in this study suggest that the CPPD-
induced lipid bilayer leakage is not due to changes in mo-
bility as we thought previously (1). Instead, we propose that
the CPPD induces an electrostatic ﬁeld distribution across
the lipid bilayer, which allows the water molecules to move
across the bilayer toward the crystal. Hence, when PC is
bound to the CPPD crystal, this electrostatic ﬁeld is shielded
and the waters are not pulled toward the crystal. To in-
vestigate the role that the electrostatic ﬁeld plays in the
CPPD-induced bilayer rupture, we have calculated the elec-
trostatic potential maps for the system under the investiga-
tion. Fig. 5 displays the GRASP (17) electrostatic potential
maps for the hydrated phospholipid bilayer alone (Fig. 5 A),
the hydrated phospholipid bilayer-CPPD system (Fig. 5 B),
and the hydrated phospholipid bilayer-CPPD-PC system
(Fig. 5 C), taken after 200 ps of molecular dynamics sim-
ulation. For the hydrated bilayer (Fig. 5 A) the electrostatic
ﬁeld is essentially slightly positive (light blue) everywhere
except within the layer of the phosphate headgroups of the
DMPC assembly. Introduction of the CPPD crystal slab (Fig.
5 B) results in dramatic changes in the distribution of
electrostatic potential within the bilayer. As one can see from
this picture, the crystal slab generates an oriented, dipole-like
electrostatic ﬁeld distribution in the immediate vicinity of the
crystal, with the positive and negative areas of electrostatic
potential clearly separated by the crystal slab. We can see
that this dipole-like ﬁeld extends deeply into the bilayer with
the electrostatic ﬁeld distribution within the bilayer being
positive (blue) on the CPPD crystal side of the bilayer and
negative on the opposite side of the bilayer (red). Thus, this
‘‘induced polarization’’ of the bilayer seems to have an
opposite direction to the dipole ﬁeld of the slab, and clearly
one can see evidence of a gradient of the electrostatic
potential across the bilayer. The presence of this directional
electrostatic ﬁeld may explain why, as it was mentioned
earlier in our simulations of the bilayer-CPPD system, we
observed that the penetrating water molecules were all
oriented in the same way, with oxygen atoms pointing at the
crystal and hydrogen atoms pointing away from the crystal.
When the CPPD crystal slab is covered with phosphocitrate,
the electrostatic ﬁeld of the crystal slab is dramatically
altered (Fig. 5 C). The positive side of this ﬁeld (blue) stays
localized very close to the surface of the crystal, and the
electrostatic potential inside the bilayer resembles very
closely that of the free bilayer (Fig. 5 A), staying in general
on the slightly positive side of the potential (light blue) as in
Fig. 5 A. There is no evidence of the electrostatic potential
gradient in the direction perpendicular to the crystal surface.
The results discussed above clearly demonstrate that phos-
phocitrate molecules distributed at the CPPD crystal surface
can protect the structural integrity of the phospholipid bilayer
by not allowing the electrostatic ﬁeld of the crystal to pene-
trate into the bilayer.
In conclusion, we propose that the CPPD-induced bi-
layer rupture is more of an electrostatic-induced and less of
a mechanics-induced phenomenon. More importantly, we
show that phosphocitrate can prevent CPPD-induced mem-
branolysis of the phospholipid bilayers. Results of this study
FIGURE 4 Distribution of the angle between the bilayer normal and lipid
headgroup (vector deﬁned by P and N atoms of the headgroup). The
distribution of the angle between the bilayer normal and vector deﬁned by P
and N atoms of the headgroup is plotted. The number of occurrences is
plotted on the y axis and histogram bins on the x axis. The solid bars
represent the bottom leaﬂet (in contact with CPPD and CPPD-PC systems),
and the open bars represent the top leaﬂet of the lipid bilayer. Plots for (A)
lipid, (B) lipid-CPPD, and (C) lipid-CPPD-PC systems are shown.
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provide a molecular model that explains why subjecting the
CPPD crystals in vivo to phosphocitrate could signiﬁcantly
diminish the interactions between the CPPD crystals and
phospholipid bilayers and thus phosphocitrate could serve as
a potentially powerful therapeutic agent in crystal-induced
arthritic diseases.
We thank Dr. Anthony Nicholls for his help in generating the GRASP (17)
images shown in Fig. 5.
We acknowledge Pittsburgh Supercomputing Center (grants MCA02N008P
and MCB020003P) for its generous allowance of the supercomputer
time. We also acknowledge the National Institutes of Health grant
(AR38421-14) and Veterans Administration Merit Review for supporting
this research.
FIGURE 5 GRASP (17) electrostatic potential plots for (A) hydrated phospholipid bilayer, (B) hydrated phospholipid bilayer and the CPPD crystal, (C)
hydrated phospholipid bilayer and PC-CPPD system. The plots show the electrostatic potential distribution after 200 ps of molecular dynamics simulation in
a plane through the center of the collection of molecules. The in-plane line contours are at (30, 15, 0, 15, 30), (blue, green, gray, yellow, and red),
respectively, and the in-plane colors range is (50,0,50) in units of kT/e (¼ 0.591 kcal/e).
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